Satellos Bioscience Inc. (MSCLF) Research

Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug. This therapeutic seeks to rectify muscle stem cell polarity, which in turn is intended to restore the body's natural processes for muscle repair and regeneration. The enterprise was founded in 2012 and operates from its primary offices located in Toronto, Canada.

Market snapshot

Symbol
MSCLF
Price
$6.25
Day change
+11.81%
Market cap
$63.2M
P/E ratio
-1.76x
52-week range
0.88-12.5
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • BioStem Technologies, Inc. (BSEM)
  • H-Source Holdings Ltd. (HSCHF)
  • Imugene Limited (IUGNF)
  • Kintor Pharmaceutical Limited (KNTPF)
  • Paradigm Biopharmaceuticals Limited (PBIGF)
  • Poolbeg Pharma PLC (POLBF)
  • Alterity Therapeutics Limited (PRNAF)
  • Starpharma Holdings Limited (SPHRY)

Open Satellos Bioscience Inc. (MSCLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.